Article Details

Kinksa Pharmaceuticals stock tumbles after treatment of COVID-related ARDS disappoints ...

Retrieved on: 2021-12-28 12:52:02

Tags for this article:

Click the tags to see associated articles and topics

Kinksa Pharmaceuticals stock tumbles after treatment of COVID-related ARDS disappoints .... View article details on hiswai:

Excerpt

The stock has rallied 7.1% over the past three months through Monday, while the iShares Biotechnology ETF IBB, -0.85% has dropped 5.4% and the S&P ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up